Valuation: Median Technologies

Market Cap 174M 202M 164M 149M 281M 19.35B 285M 1.92B 754M 9.68B 758M 742M 32.23B P/E 2026 *
-10.4x
P/E 2027 * -12.1x
Enterprise Value 191M 222M 180M 164M 308M 21.23B 312M 2.11B 828M 10.62B 832M 814M 35.37B EV / Sales 2026 *
7.53x
EV / Sales 2027 * 6.01x
Free-Float
97.93%
Yield 2026 *
-
Yield 2027 * -
1 week+10.19%
Current month+11.00%
1 month+13.08%
3 months-11.33%
6 months+0.89%
Current year-5.81%
1 week 4.13
Extreme 4.13
4.83
1 month 3.86
Extreme 3.86
4.83
3 years 1.17
Extreme 1.166
7.3
5 years 1.17
Extreme 1.166
17.46
Manager TitleAgeSince
Chief Executive Officer 64 2001-12-31
Director of Finance/CFO - 2021-07-11
Investor Relations Contact - 2019-03-31
Director TitleAgeSince
Chairman 64 2001-12-31
Chairman 64 2019-04-09
Director/Board Member 66 2017-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-3.40%+15.62%+74.62%-10.45% 207M
+0.60%-2.64%+20.82%+10.64% 216B
-1.51%-3.79%-4.51%-20.62% 142B
+0.22%-2.50%-18.72%+36.80% 138B
-1.87%-1.41%-51.02%+0.56% 74.53B
+0.19%-2.86%+16.19%+18.80% 52.34B
+1.18%-0.33%-16.45%-13.29% 50.28B
-0.01%-0.70%+25.64%+24.48% 41.93B
-1.59%-3.31%+38.65%+48.61% 40.06B
+0.36%-0.16%-0.74%+6.25% 32.69B
Average -0.27%-1.80%+8.45%+10.18% 87.63B
Weighted average by Cap. -0.22%-2.30%+0.15%+10.11%

Financials

2026 *2027 *
Net sales 25.43M 29.45M 23.93M 21.75M 40.91M 2.82B 41.51M 281M 110M 1.41B 111M 108M 4.7B 33.43M 38.71M 31.46M 28.59M 53.77M 3.71B 54.56M 369M 145M 1.85B 145M 142M 6.18B
Net income -15.23M -17.64M -14.33M -13.03M -24.5M -1.69B -24.86M -168M -65.89M -845M -66.22M -64.78M -2.82B -11.23M -13.01M -10.57M -9.61M -18.07M -1.25B -18.33M -124M -48.59M -623M -48.83M -47.77M -2.08B
Net Debt 17M 19.68M 15.99M 14.54M 27.34M 1.89B 27.74M 188M 73.53M 943M 73.9M 72.29M 3.14B 26.5M 30.68M 24.93M 22.66M 42.62M 2.94B 43.25M 292M 115M 1.47B 115M 113M 4.9B
Logo Median Technologies
A pioneer in innovative imaging services and device software, Median Technologies (Median) leverages cutting-edge Artificial Intelligence (AI) technologies to increase the accuracy of early diagnosis and treatment of many cancers. Median's offerings, iCRO for the analysis and management of medical images in oncology clinical trials and eyonis® LCS, a suite of medical device software based on AI technologies, enable biopharmaceutical companies and clinicians to advance patient care and accelerate the development of new therapies. Median is also present in the United States and China.
Employees
-
Date Price Change
26-08-18 €4.540 -3.40%
26-08-17 €4.700 +0.11%
26-08-14 €4.695 -0.53%
26-08-13 €4.720 +3.40%
26-08-12 €4.565 +10.80%
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
4.570EUR
Average target price
11.97EUR
Spread / Average Target
+161.85%

Annual profits - Rate of surprise